[1]
Dr. Shivani Sodhi et al. 2025. FOLFOX AND FOLFIRI CHEMOTHERAPY IN A METASTATIC COLORECTAL CANCER PATIENT: A CASE REPORT OF DUAL REGIMEN INTOLERANCE. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 686–690. DOI:https://doi.org/10.53555/zmv9pm80.